Trial of atosiban for women with past implantation failure and abnormal uterine contractions
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests if atosiban, a medicine that relaxes the uterus, can help women who have had multiple failed embryo transfers. It's for women whose uterus has abnormal contractions, which might prevent embryos from implanting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to transfer one embryo (fresh or frozen) at the blastocyst stage.
- You have had at least one previous embryo transfer that did not lead to pregnancy.
- You are between 20 and 40 years old.
- You have abnormal uterine contractions seen on an ultrasound on the morning of your embryo transfer.
- You can only join this trial for one transfer cycle.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether blood-thinning medication can improve the chance of pregnancy in women who have trouble conceiving. It focuses on how the medication affects the lining of the womb and its ability to accept an embryo.
This trial tests whether a 2-3 month hormone treatment before a frozen embryo transfer improves pregnancy success in women with deep endometriosis. It may help your body prepare better for the embryo.
This trial explores how natural uterine contractions affect pregnancy success in women using hormone therapy for frozen embryo transfer. It may help doctors understand if uterine activity influences implantation.
This trial tests whether infusing special stem cells (from donated bone marrow) into the uterine artery can help thicken the womb lining in women with severe uterine scarring (adhesions) and a history of failed embryo transfers due to thin lining. The goal is to make it possible to successfully implant a frozen embryo and achieve pregnancy.
This trial studies whether adding acupuncture during embryo transfer and hormone treatment can improve pregnancy outcomes for women who have had repeat IVF implantation failures with no known cause. It may help your chance of clinical pregnancy when you transfer good-quality frozen embryos.
This study tests whether taking a medication called nintedanib before embryo transfer improves pregnancy chances in women with adenomyosis. Nintedanib may help by reducing inflammation and abnormal blood vessels in the uterus linked to adenomyosis.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.